Evidence map›Paper›PMID 32300927›Full record

ArticleCurrent microbiology2020

Effects of Cefazolin and Meropenem in Eradication Biofilms of Clinical and Environmental Isolates of Proteus mirabilis.

Sivoneide Silva, Lívia Araújo, José Adelson Nascimento Junior, Túlio Silva, Ana Catarina Lopes, Maria Tereza Correia, Márcia Silva, Maria Betânia Oliveira

Abstract read
PubMed Publisher
In one paragraph

Article in Current microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sivoneide SilvaDepartamento de Bioquímica, Centro de Biociências - Universidade Federal de Pernambuco, Av. Moraes Rego s/n, Recife, PE, Brazil.
Lívia AraújoDepartamento de Bioquímica, Centro de Biociências - Universidade Federal de Pernambuco, Av. Moraes Rego s/n, Recife, PE, Brazil.
José Adelson Nascimento JuniorDepartamento de Bioquímica, Centro de Biociências - Universidade Federal de Pernambuco, Av. Moraes Rego s/n, Recife, PE, Brazil.
Túlio SilvaCentro de Tecnologias Estratégicas Do Nordeste (CETENE), Recife, PE, Brazil.
Ana Catarina LopesDepartamento de Medicina Tropical, Centro de Ciências da Saúde - Universidade Federal de Pernambuco, Recife, PE, Brazil.
Maria Tereza CorreiaDepartamento de Bioquímica, Centro de Biociências - Universidade Federal de Pernambuco, Av. Moraes Rego s/n, Recife, PE, Brazil.
Márcia SilvaDepartamento de Bioquímica, Centro de Biociências - Universidade Federal de Pernambuco, Av. Moraes Rego s/n, Recife, PE, Brazil.
Maria Betânia OliveiraDepartamento de Bioquímica, Centro de Biociências - Universidade Federal de Pernambuco, Av. Moraes Rego s/n, Recife, PE, Brazil. mbetaniam2008@gmail.com.
Universidade Federal de Pernambuco · BRCentro de Tecnologias Estratégicas do Nordeste · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Proteus mirabilis is an opportunistic Gram-negative bacterium belonging to the family Enterobacteriaceae and is known for its ability to cause urinary tract infections. The aim of this study was to determine the value of the minimum concentration of cefazolin and meropenem on biofilm eradication, as well as the resistance profiles and genetic diversity of clinical and environmental isolates of P. mirabilis. We compared the isolates collected from a hospital environment and from an urban stream impacted in Recife-Pernambuco, Brazil. Biochemical tests were performed to determine the profiles of susceptibility, hydrophobicity, biofilm formation and eradication. The genetic diversity was verified using the ERIC-PCR method. The results revealed that two clinical isolates (ICP4 and ICP5) were multi-drug resistant, whereas the environmental isolates showed resistance only to tetracycline, except for CP

Indexed as

Anti-Bacterial AgentsBiofilmsBrazilCefazolinDrug Resistance, Multiple, BacterialGenetic VariationHumansMeropenemMicrobial Sensitivity TestsProteus InfectionsProteus mirabilisAnti-Bacterial AgentsCefazolinMeropenem

Identifiers

PMID32300927
OpenAlexW3016584643

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.